In this issue of Blood, Ceriani et al introduce, in primary mediastinal B-cell lymphoma (PMBCL), a new prognostic factor measured on pretreatment 18F-fluorodeoxyglucose (18FDG)-positron emission tomography (PET)/computed tomography (CT): the total lesion glycolysis (TLG), which is an index of the glucose uptake by the total tumor burden. This paper is part of the International Extranodal Lymphoma Study Group (IELSG) 26 prospective study designed to evaluate the role of PET in the treatment of PMBCL.
Keyphrases
- positron emission tomography
- computed tomography
- prognostic factors
- pet ct
- pet imaging
- diffuse large b cell lymphoma
- dual energy
- image quality
- magnetic resonance imaging
- contrast enhanced
- lymph node
- type diabetes
- risk factors
- metabolic syndrome
- insulin resistance
- adipose tissue
- mass spectrometry
- skeletal muscle
- combination therapy
- ultrasound guided